SUBSCRIBE TO TMCnet
TMCnet - World's Largest Communications and Technology Community

TMC NEWS

TMCNET eNEWSLETTER SIGNUP

Mentor Capital Discusses Opioids vs. Cannabis at Congressman Rohrabacher Reception
[March 07, 2017]

Mentor Capital Discusses Opioids vs. Cannabis at Congressman Rohrabacher Reception


Mentor Capital, Inc. (OTCQB: MNTR) met with Congressman Dana Rohrabacher of Newport Beach at his reception by the Cannabis Host Committee in San Diego, March 6th, 2017. Mentor CEO Chet Billingsley, nicknamed "The Doc" by the Congressman, outlined in discussion how 20% of the opiate crises and 6,000 annual deaths could be avoided by the projected 20% substitution to legal cannabis from other illegal drugs that would follow a national marijuana legalization. Too much cannabis puts the user to sleep, but too much opiate, heroin or even alcohol can "relax" breathing to zero and overdose death. An additional 6,000 lives are saved by an observed 7% shift from alcohol.

Congressman Rohrabacher spoke to the exclusive group of major cannabis leaders on freedom as a cornerstone American value that is violated whenever a peaceful cannabis user is dragged off to be caged. He jokingly held a Moscow Mule drink in hand and asked how even in this time of Russian hysteria how could this rowdy alcohol be accepted and mellowing cannabis not be. The Congressman also railed against the practice of asset forfeiture being applied against legal cannabis firms without trial or even charges being levied. Reporting on his own Washington, DC cannabis prognosis, he felt that the campaign promise by now President Trump that cannabis use should be governed by the choices of each state, would prevail.

Following the political overview by Congressman Rohrabacher, the founders of the larger cannabis companies met with CEO Billingsley to explore how Mentor may provide public market liquidity and funding for their long-established medical marijuana and adult use cannabis enterprises.

About Mentor Capital: The Company seeks to come alongside and assist private medical marijuana and cannabis companies and their founders in meeting their liquidity and financial objectives, to add protection for investors and to help incubate private cannabis companies. Additional important information for investors is presented at: www.MentorCapital.com.

This press release is neither an offer to sell, nor a solicitation of offers to purchase, securities.


Forward-Looking Statements: This press release contains forward-looking statements within the meaning of the federal securities laws, including statements concerning financial projections, financing activities, corporate combinations, product development activities and sales and licensing activities. Such forward-looking statements are not guarantees of future results or performance, are sometimes identified by words of condition such as "should," "could," "expects," "may," "intends," "seeks," "looks," "moves," or "plans" and are subject to a number of risks and uncertainties, known and unknown, that could cause actual results to differ materially from those intended or anticipated. Such risks include, without limitation: nonperformance of investments, partner and portfolio difficulties, potential delays in marketing and sales, problems securing the necessary financing to continue operations, problems involving continued illegality of cannabis products, potential of competitive products, services, and technologies, difficulties experienced in product development, in recruiting knowledgeable personnel, in collecting judgments and in protecting intellectual property. Further information concerning these and other risks is included in the Company's Form 10-K and 10-Q filings which, along with other very important information about the Company, can be found here:

http://mentorcapital.com/disclosures/

The Company undertakes no obligation to update or revise such forward-looking statements to reflect new information, events or circumstances occurring after the date of this press release.


[ Back To TMCnet.com's Homepage ]






Technology Marketing Corporation

35 Nutmeg Drive Suite 340, Trumbull, Connecticut 06611 USA
Ph: 800-243-6002, 203-852-6800
Fx: 203-866-3326

General comments: tmc@tmcnet.com.
Comments about this site: webmaster@tmcnet.com.

STAY CURRENT YOUR WAY

© 2017 Technology Marketing Corporation. All rights reserved | Privacy Policy